Sg3 Management, LLC Travere Therapeutics, Inc. Call Options Transaction History

Sg3 Management, LLC

  • $0
  • Q3 2023

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$20.94 - $30.01 $705,678 - $1.01 Million
-33,700 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$23.61 - $30.6 $795,657 - $1.03 Million
33,700 New
33,700 $868,000
Q2 2021

Aug 16, 2021
SELL
$14.11 - $26.4 $529,125 - $990,000
-37,500 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$23.37 - $31.77 $876,375 - $1.19 Million
37,500 New
37,500 $936,000

Others Institutions Holding TVTX

# of Institutions
184
Shares Held
89.5M
Call Options Held
66.9K
Put Options Held
265K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $560M
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email